DD280396A5 - Verfahren zur bestimmung einer immunologisch bindefaehigen polyvalenten substanz - Google Patents

Verfahren zur bestimmung einer immunologisch bindefaehigen polyvalenten substanz Download PDF

Info

Publication number
DD280396A5
DD280396A5 DD89326088A DD32608889A DD280396A5 DD 280396 A5 DD280396 A5 DD 280396A5 DD 89326088 A DD89326088 A DD 89326088A DD 32608889 A DD32608889 A DD 32608889A DD 280396 A5 DD280396 A5 DD 280396A5
Authority
DD
German Democratic Republic
Prior art keywords
igg
specific
aggregates
fab
reactants
Prior art date
Application number
DD89326088A
Other languages
German (de)
English (en)
Inventor
Helmut Lenz
Ellen Moessner
Werner Stock
Norbert Franken
Robert C Mccarthy
Albert Roeder
Harald Haug
Original Assignee
��@���������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��@���������@�������k�� filed Critical ��@���������@�������k��
Publication of DD280396A5 publication Critical patent/DD280396A5/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
DD89326088A 1988-03-03 1989-02-28 Verfahren zur bestimmung einer immunologisch bindefaehigen polyvalenten substanz DD280396A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/164,054 US4914040A (en) 1988-03-03 1988-03-03 Reagent and method for determination of a polyvalent substance using an immunoaggregate

Publications (1)

Publication Number Publication Date
DD280396A5 true DD280396A5 (de) 1990-07-04

Family

ID=22592781

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89326088A DD280396A5 (de) 1988-03-03 1989-02-28 Verfahren zur bestimmung einer immunologisch bindefaehigen polyvalenten substanz

Country Status (18)

Country Link
US (1) US4914040A (xx)
EP (1) EP0331068B1 (xx)
JP (1) JPH0823560B2 (xx)
AT (1) ATE82072T1 (xx)
AU (1) AU616484B2 (xx)
CA (1) CA1340572C (xx)
DD (1) DD280396A5 (xx)
DE (2) DE3905505A1 (xx)
DK (1) DK175429B1 (xx)
ES (1) ES2045216T3 (xx)
FI (1) FI92879C (xx)
GR (1) GR3006991T3 (xx)
HU (1) HU212322B (xx)
IE (1) IE62974B1 (xx)
LV (1) LV10538B (xx)
PT (1) PT89889B (xx)
RU (1) RU2032906C1 (xx)
ZA (1) ZA891568B (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3730059A1 (de) * 1987-09-08 1989-03-30 Behringwerke Ag Verfahren zur bestimmung von "loeslichem" fibrin
US5141853A (en) * 1988-07-22 1992-08-25 Abbott Laboratories Determination of ammonia levels in a sample
DE3829245A1 (de) * 1988-08-29 1990-03-01 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz
AU6710790A (en) * 1989-10-24 1991-05-31 E.I. Du Pont De Nemours And Company Use of polymerized immunoglobulin to reduce the incidence of false-positive responses in immunoassays
US6274325B1 (en) 1990-06-25 2001-08-14 Boehringer Mannheim Gmbh Method for carrying out a homogeneous-immunoassay based on agglutination
DE4020204A1 (de) * 1990-06-25 1992-01-02 Boehringer Mannheim Gmbh Durchfuehrung eines homogenen immunoassays nach dem agglutinationsprinzip
JPH04350559A (ja) * 1991-05-28 1992-12-04 Dai Ichi Pure Chem Co Ltd 特異抗体の測定法
DE69217957T2 (de) * 1991-07-26 1997-08-07 Dade Chemistry Systems Inc Verfahren zur beseitigung von falschen ergebnissen in einem immunoassay
US5460944A (en) * 1991-10-28 1995-10-24 Boehringer Mannheim Gmbh Storable protein solution
DE4202923A1 (de) * 1992-02-01 1993-08-05 Behringwerke Ag Verfahren zur bestimmung von antigenen oder antikoerpern in gegenwart eines immunkomplexes
IL102495A (en) * 1992-07-14 1998-06-15 Patchornik Avraham Universal standard reagents, method of preparing same and use thereof
IL106887A (en) * 1993-09-02 1997-02-18 Yissum Res Dev Co Pharmaceutical and diagnostic compositions and a method for drug targeting
GB9403215D0 (en) * 1994-02-19 1994-04-13 Kodak Ltd Chemical modification of antibodies and antigens
DE4407423A1 (de) * 1994-03-05 1995-09-07 Boehringer Mannheim Gmbh Entstörmittel zum Einsatz bei Immunoassays
JP3027770B2 (ja) * 1994-03-05 2000-04-04 ロシュ ダイアグノスティックス ゲーエムベーハー イムノアッセイで使用するための干渉除去剤
DE4439452A1 (de) * 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz
DE19621133A1 (de) * 1996-05-24 1997-11-27 Boehringer Mannheim Gmbh Bestimmungsverfahren mit oligomerisierten Rezeptoren
DE19731465A1 (de) 1997-07-22 1999-01-28 Boehringer Mannheim Gmbh Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren
ATE225511T1 (de) * 1997-12-11 2002-10-15 Roche Diagnostics Gmbh Entstörung von diagnostischen verfahren durch peptide aus d-aminosäuren
DE19828466A1 (de) * 1998-06-26 1999-12-30 Roche Diagnostics Gmbh Entstörung von Immunoassays durch Substanzen, die aus den Framework-Regionen von Antikörpern abgeleitet sind
US6406858B1 (en) * 1998-11-27 2002-06-18 Bayer Corporation System for the reduction of interferences in immunoassays
JP2004510161A (ja) * 2000-09-25 2004-04-02 アボット・ラボラトリーズ 高分子ポリカチオンを用いることにより、特異的結合アッセイにおける血清または血漿含有アッセイ試料の干渉を減少させるための方法及びキット
DE10059720A1 (de) 2000-11-30 2002-06-06 Roche Diagnostics Gmbh Verwendung intramolekular kovalent vernetzter Proteine als Bindepartner in Immunoassays
DE10064827A1 (de) 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
US20040091952A1 (en) * 2002-07-25 2004-05-13 Sysmex Corporation Reagent kit for detecting lupus anticoagulant
US20040018556A1 (en) * 2002-07-29 2004-01-29 Cantor Thomas L. Reagent and method for determination of a substance using an immunoaggregator
DE602004016906D1 (de) * 2003-03-28 2008-11-20 Sysmex Corp Reagenz zum Nachweis von anti-Phospholipid Antikörper
CA2532023A1 (en) * 2003-07-08 2005-01-13 Inverness Medical Switzerland Gmbh Particle agglutination detection method and device
US20050112586A1 (en) * 2003-11-24 2005-05-26 Roland Janzen Method and composition for stabilizing liquid reagents
EP1562047B1 (en) * 2004-02-06 2008-05-14 Sysmex Corporation Reagent kit for detecting lupus anticoagulant
WO2005121795A1 (ja) * 2004-06-14 2005-12-22 Kyowa Medex Co., Ltd. 非特異反応が抑制された免疫測定方法および試薬
CN101120249A (zh) * 2004-11-15 2008-02-06 因韦尔尼斯医药瑞士股份有限公司 血型方法系统以及装置
US7172906B2 (en) * 2004-11-16 2007-02-06 Dade Behring Inc. Reduction of non-specific binding in assays
WO2009025364A1 (ja) * 2007-08-23 2009-02-26 Mitsubishi Kagaku Iatron, Inc. 非特異反応抑制剤
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2019207115A1 (en) * 2018-04-26 2019-10-31 Statens Serum Institut Improved immunoassays
CN109342743B (zh) * 2018-12-05 2022-02-18 菲鹏生物股份有限公司 一种能够与类风湿因子高效结合的变性IgG的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083869B1 (en) * 1982-01-05 1985-10-16 International Institute Of Cellular And Molecular Pathology (Icp) Method of immunoassay
DE3206729A1 (de) * 1982-02-25 1983-09-01 Behringwerke Ag, 3550 Marburg Immunologisches agglutinationsverfahren
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4474892A (en) * 1983-02-16 1984-10-02 Board Of Trustees Of The Leland Stanford Junior University Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
US4582810A (en) * 1983-09-30 1986-04-15 Becton, Dickinson And Company Immuno-agglutination particle suspensions
JPS60256057A (ja) * 1984-06-01 1985-12-17 Dai Ichi Pure Chem Co Ltd 免疫学的測定法
JPS6165162A (ja) * 1984-09-05 1986-04-03 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体を用いた免疫学的測定方法における非特異反応吸収剤
JPH0799372B2 (ja) * 1985-07-13 1995-10-25 富士レビオ株式会社 逆受身凝集反応用非特異反応吸収剤

Also Published As

Publication number Publication date
JPH01254869A (ja) 1989-10-11
CA1340572C (en) 1999-06-01
AU616484B2 (en) 1991-10-31
RU2032906C1 (ru) 1995-04-10
DK175429B1 (da) 2004-10-18
DK96689D0 (da) 1989-02-28
GR3006991T3 (xx) 1993-06-30
IE62974B1 (en) 1995-03-08
FI891012A0 (fi) 1989-03-02
EP0331068A1 (de) 1989-09-06
DK96689A (da) 1989-09-04
HU212322B (en) 1996-05-28
AU3090889A (en) 1989-09-07
LV10538A (lv) 1995-02-20
ZA891568B (en) 1989-11-29
HUT50988A (en) 1990-03-28
LV10538B (en) 1995-12-20
EP0331068B1 (de) 1992-11-04
FI92879B (fi) 1994-09-30
DE3905505A1 (de) 1989-09-14
FI92879C (fi) 1995-01-10
ES2045216T3 (es) 1994-01-16
US4914040A (en) 1990-04-03
IE890683L (en) 1989-09-03
FI891012A (fi) 1989-09-04
PT89889B (pt) 1994-05-31
PT89889A (pt) 1989-11-10
DE58902586D1 (de) 1992-12-10
JPH0823560B2 (ja) 1996-03-06
ATE82072T1 (de) 1992-11-15

Similar Documents

Publication Publication Date Title
EP0331068B1 (de) Immunoassay und -rolymere IgG-Derivate zur Kompensation von Störfaktoren in Immunoassays
EP0098590B1 (de) Immunchemisches Messverfahren
EP0397113B1 (de) Verfahren zum Nachweis spezifisch bindefähiger Substanzen in Körperflüssigkeiten
DE68920693T2 (de) Gefriergetrocknete Zusammensetzung, die ein mit Meerrettichperoxydase markiertes Fab'-Fragment eines gegen menschliches Beta-Interferon gerichteten Antikörpers und Trehalose enthält; EIA Kit, der diese Zusammensetzung enthält.
EP0280211B1 (de) Verfahren zur Bestimmung von Antikörpern
EP0269092B1 (de) Verfahren zur Bestimmung einer spezifisch bindefähigen Substanz
EP0363942B1 (de) Verfahren zur Bestimmung einer spezifisch bindefähigen Substanz
CH645465A5 (de) Immunbiologisches verfahren zur quantitativen bestimmung von haptenen und testausruestung zur durchfuehrung des verfahrens.
DE69021953T2 (de) Enzymimmuntest für Antigene und dafür verwendbare feste Phase.
EP0174652B1 (de) Immunchemisches Messverfahren für Haptene und Proteine
DE19649389A1 (de) Antigenspezifischer IgM-Nachweis
EP0291086B1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten
WO1996014338A1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
EP0243655B1 (de) Verfahren und Reagenz zur Bestimmung eines Reaktionspartners einer immunologischen Reaktion
EP0289003B1 (de) Immunchemisches Verfahren und Reagenz zur Bestimmung eines polyvalenten Antigens in einer flüssigen Probe
EP0147848A2 (de) Verfahren zur Bestimmung eines polyvalenten Antigens und Reagenz hierfür
DE3883145T2 (de) Verfahren zur Messung von humanen Insulin.
EP0322813A2 (de) Verfahren zur Bestimmung einer immunologisch aktiven Substanz
EP0249877B1 (de) Verfahren zur Herstellung eines immunreaktiven Trägermaterials für die heterogene immunologische Analyse
DE69526143T2 (de) Abtrennfreier, spezifischer Bindungsassay mit Anti-Inhibitor-Antikörpern
DE3852166T2 (de) Analytische Vorrichtung für enzymimmunologische Tests.
EP0444561B1 (de) Verfahren zur immunologischen Bestimmung von Liganden
EP0464554B1 (de) Durchführung eines homogenen Immunoassays nach dem Agglutinationsprinzip

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee